15 May Peptide Research Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes Posted by New England Biologics May 15, 2025 0 Published in The New England Journal of Medicine on June 13, 2019, this study evaluates the cardiovascular safety and efficacy of oral ... Continue reading